Probeam

Rx: 40Gy/5fx to pancreas

50Gy to liver metastases (SIB)

2022 AAMD Plan Study

http://medicalaffairs.varian.com/image/badge_award-128_clean_red90.png

 

Beams
DVH
ScoreCard Metrics
Technical Plan Comments

This 3 field plan scored 144.36 out 150 in the 2022 AAMD-Plan Study: SBRT pancreas+Liver Mets (rank of 12 out of 203 submissions).

The plan includes three fields. All beams were positioned manually taking into account the shortest path length, the most homogeneous path through healthy tissue, and avoiding distal fall-off overlap. A ring was also used during optimization to help achieve the conformation number.  Plan quality and score would likely have been further improved with more fields. 

Comparative Plan Quality
Links

3rd party software plan report

Download associated

DICOM patient export

PDF

ESAPI PlanScoreCard metrics

ZIP

 

optimization objectives

 

Any reference to a "plan study" are simply what the organizers call each case and may not be a "study" in the FDA sense as they may not have been published in a peer reviewed journal.
Varian does not provide medical advice and these are illustrative examples only.
Leading plans by expert planner. Your results may vary.

FOR EDUCATIONAL AND SCIENTIFIC EXCHANGE ONLY – NOT FOR SALES OR PROMOTIONAL USE.